GUAN, X.; WANG, L.; CAO, Y.; SHI, F.; XU, H.; DING, J.; WU, M.; LI, H. A Erratum on Cost effectiveness analysis of blonanserin versus ziprasidone as first-line treatment for patients with schizophrenia in China. Health Decision, [S. l.], v. 1, 2023. DOI: 10.54844/hd.2023.0498. Disponível em: https://www.hksmp.com/journals/hd/article/view/498. Acesso em: 11 may. 2024.